Loading insider details...
Beta
Latest Form 4 (Jan 9, 2026): Grant/Award of 300,000 SLS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 9, 2026 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 300,000 | n/a |
| Dec 5, 2025 | SELLAS Life Sciences Group, Inc. (SLS) | Other (see footnotes) | 58,592 | $87.9K |
| Jan 14, 2025 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 113,000 | n/a |
| Dec 5, 2024 | SELLAS Life Sciences Group, Inc. (SLS) | Other (see footnotes) | 7,165 | $8.1K |
| Jan 25, 2024 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 47,000 | n/a |
| Dec 8, 2023 | SELLAS Life Sciences Group, Inc. (SLS) | Other (see footnotes) | 2,929 | $3.2K |
| Feb 3, 2023 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 20,000 | n/a |
| Dec 5, 2022 | SELLAS Life Sciences Group, Inc. (SLS) | Sale | 1,159 | $3.0K |
| Feb 1, 2022 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 9,600 | n/a |
| Dec 3, 2021 | SELLAS Life Sciences Group, Inc. (SLS) | Sale | 231 | $1.4K |